{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:16:46Z","timestamp":1783199806707,"version":"3.54.6"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100023856","name":"E.J. Whitten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.euo.2026.02.015","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:29:07Z","timestamp":1771676947000},"page":"731-732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to Armando Stabile, Giorgio Gandaglia, and Francesco Montorsi\u2019s Letter to the Editor re: Jianliang Liu, Laurence Harewood, Dominic Bagguley, et al. Early Results from the CONFIRM Trial: Utility of Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography in Active Surveillance for Prostate Cancer. Eur Urol Oncol 2025;8:1118\u201325"],"prefix":"10.1016","volume":"9","author":[{"given":"Jianliang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilakavathi","family":"Chengodu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayland","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8553-5618","authenticated-orcid":false,"given":"Nathan","family":"Lawrentschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.02.015_b0005","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.euo.2025.02.010","article-title":"Early results from the CONFIRM trial: utility of prostate-specific membrane antigen positron emission tomography\/computed tomography in active surveillance for prostate cancer","volume":"8","author":"Liu","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.02.015_b0010","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00345-023-04365-4","article-title":"Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion?","volume":"41","author":"Stabile","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2026.02.015_b0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.euros.2025.05.008","article-title":"A comparison of magnetic resonance imaging assessment and biopsy outcomes with and without central review in two Swedish regional organized prostate cancer testing programs","volume":"77","author":"Wallstr\u00f6m","year":"2025","journal-title":"Eur Urol Open Sci"},{"issue":"Suppl 4","key":"10.1016\/j.euo.2026.02.015_b0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bju.16214","article-title":"The CONFIRM trial protocol: the utility of prostate-specific membrane antigen positron emission tomography\/computed tomography in active surveillance for prostate cancer","volume":"133","author":"Bagguley","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2026.02.015_b0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.prnil.2022.08.004","article-title":"Irreversible electroporation for prostate cancer using PSMA PET-CT","volume":"11","author":"Shin","year":"2023","journal-title":"Prostate Int"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:42:14Z","timestamp":1783197734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126000520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2588931126000520"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.02.015","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reply to Armando Stabile, Giorgio Gandaglia, and Francesco Montorsi\u2019s Letter to the Editor re: Jianliang Liu, Laurence Harewood, Dominic Bagguley, et al. Early Results from the CONFIRM Trial: Utility of Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography in Active Surveillance for Prostate Cancer. Eur Urol Oncol 2025;8:1118\u201325","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}